Advertisement
Person › Details
Olav Zilian (Medigene AG (FSE: MDG1, Prime Standard))
Zilian, Olav (Medigene 201601– SVP Corporate Development before Helvea SA + ISREC)
Organisation | Medigene AG (FSE: MDG1, Prime Standard) | |
Group | Medigene (Group) | |
Product | cancer immunotherapy (immuno-oncology, I-O) | |
Product 2 | financial research (analyst) | |
Record changed: 2024-11-04 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top